Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Teleflex (NYSE: TFX) announced that its Chairman, President and CEO, Liam Kelly, will be speaking at the Morgan Stanley 22nd Annual Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex (NYSE: TFX) announced that its Chairman, President and CEO, Liam Kelly, will be speaking at the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Friday, September 6, 2024, at 7:45 a.m. (ET) and will take place at the Marriott Marquis New York.
Investors and interested parties can access a live audio webcast of the conference presentation through the investor section of the Teleflex website. This presentation offers an opportunity for stakeholders to gain insights into Teleflex's current position and future strategies in the healthcare industry.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was +0.34%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 22nd Annual Global Healthcare Conference at the Marriott Marquis New York, on Friday, September 6, 2024, at 7:45 a.m. (ET).
A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.